SPK-601

CAS No. 1096687-52-3

SPK-601( LMV-601 | SPK-0601 )

Catalog No. M10375 CAS No. 1096687-52-3

A potent phosphatidylcholine-specific phospholipase C (PC-PLC) inhibitor; shows antiviral activity against herpes simplex virus (HSV).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 215 Get Quote
50MG 1782 Get Quote
100MG 2250 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    SPK-601
  • Note
    Research use only, not for human use.
  • Brief Description
    A potent phosphatidylcholine-specific phospholipase C (PC-PLC) inhibitor; shows antiviral activity against herpes simplex virus (HSV).
  • Description
    A potent phosphatidylcholine-specific phospholipase C (PC-PLC) inhibitor; shows antiviral activity against herpes simplex virus (HSV); a novel antimicrobial agent.HSV Infection Phase 1 Clinical.
  • In Vitro
    SPK-601 (72 hours; HPV-31 cells) displays a dose dependent inhibitory effect on cell growth (IC50 of 16 μg/mL), and inhibits HPV-31 specific RNA expression and DNA replication. Cell Viability Assay Cell Line:9E human papilloma virus (HPV)-31 infected cervical epithelial cells Concentration:Incubation Time:72 hours Result:A dose dependent inhibitory effect on cell growth.
  • In Vivo
    ——
  • Synonyms
    LMV-601 | SPK-0601
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    Phospholipase
  • Recptor
    Phospholipase
  • Research Area
    Infection
  • Indication
    HSV Infection

Chemical Information

  • CAS Number
    1096687-52-3
  • Formula Weight
    266.4645
  • Molecular Formula
    C11H15KOS2
  • Purity
    >98% (HPLC)
  • Solubility
    10 mM in DMSO
  • SMILES
    [S-]C(O[C@@H]1[C@@](C2)([H])[C@]3([H])CCCC3[C@@]2([H])C1)=S.[K+]
  • Chemical Name
    Carbonodithioic acid, O-[(3aR,4R,5S,7R,7aR)-octahydro-4,7-methano-1H-inden-5-yl] ester, potassium salt (1:1), rel-(-)-

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Walker K. IDrugs. 2010 Nov;13(11):743-5.
molnova catalog
related products
  • CCT129957

    CCT129957 is a novel and potent phospholipase C-γ (PLC-γ) inhibitor with an IC50 of about 3 μM and a GC50 of 15 μM.CCT129957 exhibits anticancer activity and inhibits Ca2+ release in squamous cells.

  • Lp-PLA2-IN-3

    Lp-PLA2-IN-3 is a potent, orally bioactive lipoprotein-associated phospholipase A2 (Lp-PLA2) inhibitor, effectively inhibiting recombinant human [Lp-PLA2] with an IC50 value of 14 nM.

  • Atg4B-IN-2

    Atg4B-IN-2. A potent, selective Atg4B inhibitor with anticancer activity, inhibits both Atg4B and PLA2, enabling autophagy that counteracts the anticancer activity of anti-desiccation-resistant prostate cancer drugs.